Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study-...

• Autor(es): Baptista, V ; Ferreira, S ; Pinho-e-Melo, T ; Carvalho, M ; Cruz, V ; Carmona, C ; Silva, F ; Tuna, A ; Rodrigues, M ; Ferreira, C ; Pinto, A ; Leitão, A ; Gabriel, J ; Calado, S ; Oliveira, J ; Ferro, J
• Data: 2010
• Identificador Persistente: http://hdl.handle.net/10400.10/425
• Origem: Repositório do Hospital Prof. Doutor Fernando Fonseca
• Assunto(s): Doença de Fabry; Testes genéticos; Acidente vascular cerebral; Portugal; Estudo comparativo; Estudos prospectivos; Fabry disease; Stroke; PORTYSTROKE Study
• Tipo de Documento: Artigo
• Idioma: Inglês

Descrição

BACKGROUND AND PURPOSE: Fabry disease is an X-linked monogenic disorder caused by mutations in the GLA gene. Recent data suggest that stroke in young adults may be associated with Fabry disease. We aimed to ascertain the prevalence of this disorder among young adult patients with stroke in Portugal by GLA genotyping. METHODS: During 1 year, all patients aged 18 to 55 years with first-ever stroke, who were admitted into any of 12 neurology hospital departments in Portugal, were prospectively enrolled (n=625). Ischemic stroke was classified according to Trial of Org 10172 in Acute Stroke Treatment criteria. Alpha-galactosidase activity was further assayed in all patients with GLA mutations. RESULTS: Four hundred ninety-three patients (mean age, 45.4 years; 61% male) underwent genetic analyses: 364 with ischemic stroke, 89 with intracerebral hemorrhage, 26 with subarachnoid hemorrhage, and 14 with cerebral venous thrombosis. Twelve patients had missense GLA mutations: 9 with ischemic stroke (p.R118C: n=4; p.D313Y: n=5), including 5 patients with an identified cause of stroke (cardiac embolism: n=2; small vessel disease: n=2; other cause: n=1), 2 with intracerebral hemorrhage (p.R118C: n=1; p.D313Y: n=1), and one with cerebral venous thrombosis (p.R118C: n=1). Leukocyte alpha-galactosidase activity was subnormal in the hemizygous males and subnormal or low-normal in the heterozygous females. Estimated prevalence of missense GLA mutations was 2.4% (95% CI, 1.3% to 4.1%). CONCLUSIONS: Despite a low diagnostic yield, screening for GLA mutations should probably be considered in different types of stroke. Restricting investigation to patients with cryptogenic stroke may underestimate the true prevalence of Fabry disease in young patients with stroke.